Slator 2024 Life Sciences and Language AI Report

2024 Life Sciences and Language AI Report

The 70-page Slator 2024 Life Sciences and Language AI Report provides an extensive and in-depth view of the global trends, regulations, drivers, and tailwinds of the pharmaceutical industry, and the impact that these have on the demand for language services and technology.

Specifically on technology, the report analyzes how this is shaping the life sciences industry, from regulatory systems to applications of large language models (LLM) and artificial intelligence (AI). 

This is accompanied with viewpoints about LLMs and AI from C-suite executives at global pharmaceutical companies and Contract Research Organizations (CROs).

The report also provides insight from language service providers (LSPs) and language service buyers on their use of machine translation (MT), LLMs, and AI for language services in the life sciences industry, and offers an analysis of potential use cases for this technology that are specific to pharmaceutical and clinical needs.

Report buyers and Slator Pro and Enterprise subscribers were invited to a complimentary briefing where the report’s key findings were discussed. A recording will be available for Slator Pro and Enterprise Subscribers.

Send us an email or connect via chat if you prefer to purchase the report via invoice.

Regulation is key to this industry, and this report outlines recent regulatory trends and updates in multiple key markets, from Europe and the USA to Asia-Pacific and South America. 

More specifically, it provides data insights and trends on clinical trial submissions in the European Union since the introduction of the EU’s Clinical Trial Regulation.

In addition to providing the most up-to-date information on the market size for life sciences, the report examines all the core services that LSPs offer to pharmaceutical companies and CROs, and includes insight into the changing landscape of this service offering, particularly in the transition from paper-based to electronic solutions.

This is complemented by a detailed analysis of non-core services offered by LSPs to life sciences companies globally, as well as a viewpoint on the current supplier landscape.

This report also contains a dedicated buyer insights section, where leading pharmaceutical companies and CROs offer their perspectives on key trends in procuring language services and technology, including their use of AI, LLMs, and MT in their organizations.

In summary, the report provides data and insights from regulatory bodies, industry experts, and curated sources, to help readers understand the overall trends and drivers affecting demand for language services and technology globally, with a focus on AI, MT, and LLMs.

These insights are particularly relevant for sponsors of clinical trials, contract research organizations, language service providers of all sizes, and industry investors, to make informed decisions in their line of work.

Table of Contents

Executive Summary 5
The life sciences industry at a glance: key trends and regulations shaping the industry.
Introduction6
A high level introduction to the drug development process, from test tube to medicine cabinet.
Life Sciences Industry Overview8
Analysis of the market dynamics and the transformational technology shaping the life sciences industry. Includes an in-depth analysis of recent and upcoming regulatory changes in Europe, the USA, and the Rest of the World. This section also includes an analysis of different SaaS systems taking hold in the life sciences industry and a summary of C-suite views on artificial intelligence.
Language Services in the Life Sciences Industry22
Analysis of the current market size for language services, as well as core and adjacent services driving the demand for these services. Includes an in-depth analysis of the impact of the EU’s Clinical Trials Regulation on language service demand, as well as insight into the current supplier landscape.
Language Technology & AI in the Life Sciences Industry41
In-depth analysis of the specialized technology solutions that language service providers are offering pharma and CRO clients, including the adoption and application of machine translation, large language models, and artificial intelligence specific to life sciences. Includes potential future applications of AI and LLMs for language services for clinical content.
Competitive Landscape49
Profiles of the main providers of life sciences solutions in the language industry, including niche / specialist players, as well as the main buyers of language services and technology.
Buyer Insights & Industry Trends55
Five key insights and trends from three buyers of language services and technology: one pharmaceutical company, and two contract research organizations.
Sales, Business Development, Marketing62
Read up on the key industry events for pharmaceutical companies and CROs, as well as the buyer job titles for sales outreach.
Appendix65
Glossary of industry abbreviations, as well as a comprehensive linguistic validation workflow.

How to Use This Report

The Slator 2024 Life Sciences and Language AI report can be used to gain a deeper understanding of the supply and demand of language services and technology for pharmaceutical companies and contract research organizations. 

The report contains curated sources, data, and insights to allow language service providers, pharmaceutical companies, clinical trial sponsors, contract research organizations, and industry investors, to make informed decisions in their line of work.